Speech-Language Pathologists in Freeland, PA Accepting Medicare

2 Speech-Language Pathologists found. Showing 1 - 2

Jacquelyn Kay Hoffer Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 59 Brickyard Rd, Freeland, PA 18224 Phone: 570-436-0435

Andrea Marchetti Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4 Terrace Rd, Freeland, PA 18224 Phone: 570-636-0948

News Archive

Report on species-crossing microbes and H1N1

Significant weaknesses undermine the global community's abilities to prevent, detect early, and respond efficiently to potentially deadly species-crossing microbes, such as the pandemic H1N1 influenza virus sweeping the globe, says a new report from the Institute of Medicine and National Research Council. The report provides a detailed plan for establishing and funding a comprehensive, globally coordinated system to identify novel zoonotic disease threats as early as possible wherever they arise so appropriate measures can be taken to prevent significant numbers of human illnesses and deaths, and livestock losses.

ASIR coronary CTA technique reduces radiation dose by 27%

A new low-dose coronary computed tomography angiography (CTA) technique called adaptive statistical iterative reconstruction (ASIR) can reduce the radiation dose associated with coronary CTA by 27 percent, according to a study in the September issue of the American Journal of Roentgenology (www.ajronline.org). Coronary CTA is a common heart imaging test that helps determine if fatty or calcium deposits have narrowed a patient's coronary arteries.

Study provides absolute 10-year estimates for dementia by age, sex and APOE genotype

A Danish study provides 10-year absolute risk estimates for dementia specific to age, sex and common variation in the APOE gene, which may help identify high-risk individuals who potentially could benefit from early targeted prevention.

Encouraging results from Gilead's TAF Phase 2 trial on HIV-1 infection

Gilead Sciences, Inc. today announced that a Phase 2 clinical trial evaluating tenofovir alafenamide fumarate, an investigational novel prodrug of tenofovir for the treatment of HIV-1 infection, met its primary objective.

Pathogens and Global Health highlights current debate on counterfeit medicine

The latest issue of Pathogens and Global Health highlights the current debate surrounding the under-investigated, and politically sensitive, issue of counterfeit medicine. Issue 106.2 includes an interview with Dr Paul Newton, Head of the Laos arm of the Wellcome Trust's Major Overseas Programmes, and a number of articles highlighting the technological innovations and field initiatives that are challenging this threat to global health.

Read more Medical News

› Verified 5 days ago